The Precision Hypertension Care Study

NCT02774460 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Zestril®
DRUG: Atacand®
DRUG: Norvasc®
DRUG: Hydrochlorthiazide®
DRUG: Treatment X
DRUG: Treatment Y
DRUG: Placebo

Sponsor

Uppsala University